Barclays
REPL icon

Barclays’s Replimune Group REPL Stock Holding History

Barclays’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.87M Buy
+245,000
New +$1.87M ﹤0.01% 2389
2025
Q4 		– Sell
-37,000
Closed -$155K – 5598
2025
Q3 		$155K Sell
37,000
-38,900
-51% -$249K ﹤0.01% 4441
2025
Q2 		$705K Buy
+75,900
New +$662K ﹤0.01% 3560

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barclays's REPL Position: Q1 2026 in Review

Barclays reduced its Replimune Group (REPL) stake by 69% in Q1 2026, selling an estimated $1.55M and leaving 89,622 shares worth $686K. The position accounts for ﹤0.01% of the portfolio, ranked #2990.

Barclays first reported a position in REPL in Q3 2018 and has held it in 31 quarters since. The position peaked at $3.46M in Q2 2025. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • Barclays held 89,622 shares of Replimune Group worth $686K as of Q1 2026.
  • Barclays sold 202,563 Replimune Group shares in Q1 2026, an estimated $1.55M.
  • Replimune Group made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2990 holding.
  • Barclays first reported a position in Replimune Group in Q3 2018 and has held it in 31 quarters since.
  • Barclays's Replimune Group position peaked at $3.46M in Q2 2025.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.